AI Medical Imaging Solution JLK, First in Industry to Obtain MFDS Approval

JL케이 'HelloHealth' Obtains Regulatory Approval for MFDS U-Healthcare Gateway Project

JLK's personal medical information management mobile app 'HelloHealth' (Provided by JLK)

[Asia Economy Reporter Minwoo Lee] JLKE, an artificial intelligence (AI) medical imaging solution company, has become the first in the industry to obtain device certification from the Ministry of Food and Drug Safety (MFDS) for enabling non-face-to-face communication between medical staff and patients.

JLKE announced on the 6th that it has acquired this u-healthcare gateway business license from the MFDS. The u-healthcare gateway business certification applies to devices or services that allow non-face-to-face communication between medical personnel and patients.

The certified product is the personal healthcare total management platform application (app) "HelloHealth." JLKE plans to equip HelloHealth with features that provide various information for users' personal health management, analyze X-ray, computed tomography (CT), and magnetic resonance imaging (MRI) data using AI technology, and allow the general public to easily review the meaning of the medical data. It is a mobile-centered platform that forms the core of JLKE's telemedicine business.

Kim Dongmin, CEO of JLKE, said, "HelloHealth is a solution representing JLKE's telemedicine business sector, where we are newly expanding investments. With the acquisition of the MFDS license, we will actively strive to ensure that JLKE's mobile solution is widely utilized in the telemedicine market, which has high potential for domestic introduction."

This content was produced with the assistance of AI translation services.